Lantheus Presents Results from a PYLARIFY AI™ Study at the American Urological Association (AUA) Annual Meeting
16 mai 2022 08h00 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging...
Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients
13 mai 2022 08h00 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging...
Lantheus Announces Updates to the NCCN Guidelines for PSMA PET Imaging for Prostate Cancer
11 mai 2022 08h00 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., May 11, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging...
Lantheus to Present at the UBS Global Healthcare Conference
10 mai 2022 08h30 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging...
Lantheus Holdings, Inc. Reports First Quarter 2022 Financial Results
29 avr. 2022 07h07 HE
|
Lantheus Holdings, Inc.
Worldwide revenue of $208.9 million for the first quarter 2022, representing an increase of 125.8% from the prior year period GAAP net income of $43.0 million for the first quarter 2022, compared to...
Lantheus Holdings to Host First Quarter 2022 Earnings Conference Call and Webcast on April 29, 2022 at 8:00 a.m. Eastern Time
15 avr. 2022 08h30 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., April 15, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on...
Lantheus Appoints Jean-Claude Provost, MD as Interim Chief Medical Officer
04 avr. 2022 08h00 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging...
Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development
29 mars 2022 08h00 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging...
Lantheus Holdings to Present at the Barclays Global Healthcare Conference
08 mars 2022 08h30 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging...
Lantheus to Host Inaugural Investor Day
03 mars 2022 16h30 HE
|
Lantheus Holdings, Inc.
NORTH BILLERICA, Mass, March 03, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging...